ITGB3 and neoplasm: By analyzing the BBCancer 25, a blood-based biomarkers of cancers database, we found that the expression level of integrin β3 (ITGB3) was significantly increased in the circulating tumor cells, blood, and EVs from tumor patients than in those from normal controls (Figure S1A).